Overall rank by patents
#30,459
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 17 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).
The verdict
Universidad holds 9 US patents across 17 technology areas, rank #30,459 of 50,000 tracked assignees.
Universidad DE Buenos Aires has been granted 9 US utility patents between 2017 and 2025, placing Universidad DE Buenos Aires at rank #30,459 across all assignees tracked by PlainPatent. This portfolio spans 17 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.2 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Universidad DE Buenos Aires is one of the more focused assignees in the PatentsView dataset. By volume, Universidad sits between United Animal Health, Inc. (9 patents, rank #30,455) and Universidad DE Málaga (9 patents, rank #30,463) - the closest US assignees by grant volume. The composite Innovation Score of 52.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 7 grants, compared with 2 in the 2015–2019 window, a +250% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Universidad DE Buenos Aires's 17.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 17 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Universidad DE Buenos Aires against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
UNITED ANIMAL HEALTH, INC.
9 patents
UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
9 patents
UNITED TEST AND ASSEMBLY CENTER LTD.
9 patents
UNITED WIRE, LTD
9 patents
UNIVERSIDAD DE LA FRONTERA
9 patents
UNIVERSIDAD DE LA REPUBLICA
9 patents
UNIVERSIDAD DE MURCIA
9 patents
UNIVERSIDAD DE MÁLAGA
9 patents
UNIVERSIDAD DE BUENOS AIRES
9 patents
What this shows Universidad holds 9 patents at rank #30,459, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #30,459 in granted patent volume.
Other assignees with the most granted patents in Universidad's primary technology class.
Universidad's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
53 Top 10% higher than 90% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 22.2% |
| 2022 | 2 | 22.2% |
| 2023 | 2 | 22.2% |
| 2024 | 2 | 22.2% |
| 2025 | 1 | 11.1% |
Top 15 of 17 technology areas
Overall rank by patents
#30,459
Across all tracked assignees
52.9 out of 100
How to use this portfolio
Universidad's 9 grants land it in the top 10% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.